Invention Grant
US09127077B2 Polypeptides and nucleic acids for treating ErbB2-dependent cancers
有权
用于治疗ErbB2依赖性癌症的多肽和核酸
- Patent Title: Polypeptides and nucleic acids for treating ErbB2-dependent cancers
- Patent Title (中): 用于治疗ErbB2依赖性癌症的多肽和核酸
-
Application No.: US13497924Application Date: 2010-09-23
-
Publication No.: US09127077B2Publication Date: 2015-09-08
- Inventor: Sandrine Bourdoulous , Rym Djerbi-Bouillie
- Applicant: Sandrine Bourdoulous , Rym Djerbi-Bouillie
- Applicant Address: FR Paris
- Assignee: L'Universite Paris Descartes
- Current Assignee: L'Universite Paris Descartes
- Current Assignee Address: FR Paris
- Agency: Whitham Curtis Christofferson & Cook, PC
- Priority: EP09305884 20090923
- International Application: PCT/EP2010/064055 WO 20100923
- International Announcement: WO2011/036211 WO 20110331
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/47 ; C07K14/52
Abstract:
The present invention relates to polypeptides, nucleic acids and pharmaceutical compositions suitable for use in the treatment of ErbB2 dependent-cancers, in particular of tumors overexpressing ErbB2 or expressing mutated forms of the ErbB2 gene.
Public/Granted literature
- US20120214744A1 POLYPEPTIDES AND NUCLEIC ACIDS FOR TREATING ERBB2-DEPENDENT CANCERS Public/Granted day:2012-08-23
Information query
IPC分类:
